Ciba Foundation symposium, jointly with Committee for Symposia on Drug Action, on adrenergic mechanisms

Content: Chapter 1 Opening Address (pages 1–5): Sir Henry Dale Chapter 2 Formation of Adrenergic Transmitters (pages 6–16): H. J. Schumann Chapter 3 Formation of Adrenaline and Noradrenaline (pages 17–27): Norman Kirshner Chapter 4 The Fate of Adrenaline and Noradrenaline (pages 27–39): Julius Axelrod Chapter 5 3?Methoxy?4?Hydroxymandelic Acid Excretion in Phaeochromocytoma (pages 40–44): M. Sandler and C. R. J. Ruthven Chapter 6 The Metabolism of [??14C](±)?Adrenaline in the Cat (pages 45–60): Norman Kirshner Chapter 7 Chairman's Opening Remarks (pages 61–62): H. Blaschko Chapter 8 Origin, Development and Distribution of Chromaffin Cells (pages 63–82): J. D. Boyd Chapter 9 The Storage of Amines in the Chromaffin Cell (pages 83–99): Paul Hagen and Russell J. Barrnett Chapter 10 Some Observations on the Synthesis and Storage of Catechol Amines in the Adrenaline?Containing Cells of the Suprarenal Medulla (pages 100–102): A. Bertler, N. A. Hillarp and E. Rosengren Chapter 11 Cell Types of the Adrenal Medulla (pages 103–110): Olavi Eranko Chapter 12 Chairman's Opening Remarks (pages 111–115): J. H. Gaddum Chapter 13 Release of Sympathetic Transmitter by Nerve Stimulation (pages 116–130): G. L. Brown Chapter 14 Interference with the Release of Transmitter in Response to Nerve Stimulation (pages 131–147): W. A. Bain Chapter 15 The Effects of Bretylium and Allied Agents on Adrenergic Neurones (pages 148–157): A. F. Green Chapter 16 The Persistence of Adrenergic Nerve Conduction After TM IO or Bretylium in the Cat (pages 158–161): K. A. Exley Chapter 17 Some Pharmacological Properties of Guanethidine (pages 162–172): H. J. Bein Chapter 18 Effects of Adrenaline, Noradrenaline and Isopropylnoradrenaline in Man (pages 173–189): Jean Ginsburg and A. F. Cobbold Chapter 19 Effects of Catechol Amines on Consecutive Vascular Sections (pages 190–200): Bjorn Folkow Chapter 20 Clinical Effects of Drugs Which Prevent the Release of Adrenergic Transmitter (pages 201–208): D. R. Laurence and M. L. Rosenheim Chapter 21 Bretylium (pages 209–219): R. W. D. Turner Chapter 22 Chairman's Opening Remarks: The Concept of Receptors (pages 220–222): H. O. Schild Chapter 23 Relationships Between Agonists, Antagonists and Receptor Sites (pages 223–245): B. Belleau Chapter 24 Receptors for Sympathomimetic Amines (pages 246–252): Robert F. Furchgott Chapter 25 Sympathomimetic Drugs and Their Receptors (pages 253–263): E. J. Ariens Chapter 26 Various Types of Receptors for Sympathomimetic Drugs (pages 264–274): E. J. Ariens Chapter 27 Biophysical Changes Produced by Adrenaline and Noradrenaline (pages 275–287): Edith Bulbring Chapter 28 Effect of Adrenaline on Depolarized Smooth Muscle (pages 288–294): H. O. Schild Chapter 29 The Relation of Adenosine?3?, 5??Phosphate to the Action of Catechol Amines (pages 295–304): E. W. Sutherland and T. W. Rall Chapter 30 The Action of Adrenaline on Carbohydrate Metabolism in Relation to Some of Its Pharmacodynamic Effects (pages 305–322): Lennart Lundholm and Ella Mohme?Lundholm Chapter 31 Chairman's Opening Remarks (pages 323–325): U. S. von Euler Chapter 32 Tyramine and Other Amines as Noradrenaline?Releasing Substances (pages 326–336): J. H. Burn Chapter 33 Some Observations on the Effects of Tyramine (pages 337–355): P. A. Nasmyth Chapter 34 The Actions of Sympathomimetic Amines on Tryptamine Receptors (pages 356–372): J. R. Vane Chapter 35 The Depolarizing and Blocking Action of Amphetamine in the Cat's Superior Cervical Ganglion (pages 373–381): H. Reinert Chapter 36 Chairman's Opening Remarks (pages 382–385): Marthe Vogt Chapter 37 Some Central Actions of Adrenaline and Noradrenaline When Administered into the Cerebral Ventricles (pages 386–392): Floyd R. Domer and W. Feldberg Chapter 38 Intervention of an Adrenergic Mechanism During Brain Stem Reticular Activation (pages 393–409): P. Dell Chapter 39 Electrophysiological Evidence Relating to the Role of Adrenaline in the Central Nervous System (pages 410–420): P. B. Bradley Chapter 40 The Passage of Catechol Amines Through the Blood?Brain Barrier (pages 421–423): H. Weil?Malherbe Chapter 41 Release of an Adrenaline?Like Substance by Electrical Stimulation of the Brain Stem (pages 424–431): E. Marley Chapter 42 On the Biochemistry and Possible Functions of Dopamine and Noradrenaline in Brain (pages 432–439): Arvid Carlsson, Margit Lindqvist and Tor Magnusson Chapter 43 Awakening Actions of Derivatives of Phenylalanine (pages 440–445): T. L. Chrusciel Chapter 44 Clinical Effects of Amine Oxidase Inhibitors (pages 446–453): R. T. C. Pratt Chapter 45 Clinical Results with Monoamine Oxidase Inhibitors in Psychiatry (pages 454–462): Arno Voelkel Chapter 46 Short Communication: Specific Antagonism of Dibenamine to Ergometrine (pages 463–465): H. Konzett Chapter 47 Short Communication: Adrenergic Mechanisms in Inflammation (pages 466–468): D. A. Willoughby and W. G. Spector Chapter 48 Thermoregulation in Newborn Animals (pages 469–471): R. E. Moore Chapter 49 Chairman's Closing Remarks (page 472): J. H. Burn Chapter 50 Chairman's Opening Remarks (pages 473–480): H. Blaschko Chapter 51 Short Communication: Some Problems Concerning the Storage of Catechol Amines in the Adrenal Medulla (pages 481–501): N. A. Hillarp Chapter 52 Short Communication: A New Adrenergic Mechanism (pages 502–537): J. H. Burn Chapter 53 Observations on the Localization of Noradrenaline in Homogenates of Dog's Hypothalamus (pages 539–543): T. L. Chrusciel Chapter 54 Synthesis of Catechol Amines in the Depleted Brain (pages 544–587): H. Weil?Malherbe Chapter 55 Chairman's Summary (pages 588–594): J. H. Gaddum The Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world.